Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXBW4N
|
||||
| Drug Name |
[(S)-1-((2S,3S)-2-Benzyloxy-4-oxo-azetidin-3-ylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL284984
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H27N3O5
|
||||
| Canonical SMILES |
O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@H]2[C@@H](NC2=O)OCc3ccccc3)OCc4ccccc4
|
||||
| InChI |
InChI=1S/C27H27N3O5/c31-24(29-23-25(32)30-26(23)34-17-20-12-6-2-7-13-20)22(16-19-10-4-1-5-11-19)28-27(33)35-18-21-14-8-3-9-15-21/h1-15,22-23,26H,16-18H2,(H,28,33)(H,29,31)(H,30,32)/t22-,23+,26-/m0/s1
|
||||
| InChIKey |
PSINVVCFEGJVSN-ZEVJAHDQSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.